Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Cardio-Onco-Hematology in Clinical Practice. Position Paper and Recommendations.

López-Fernández T, Martín García A, Santaballa Beltrán A, Montero Luis Á, García Sanz R, Mazón Ramos P, Velasco Del Castillo S, López de Sá Areses E, Barreiro-Pérez M, Hinojar Baydes R, Pérez de Isla L, Valbuena López SC, Dalmau González-Gallarza R, Calvo-Iglesias F, González Ferrer JJ, Castro Fernández A, González-Caballero E, Mitroi C, Arenas M, Virizuela Echaburu JA, Marco Vera P, Íñiguez Romo A, Zamorano JL, Plana Gómez JC, López Sendón Henchel JL.

Rev Esp Cardiol (Engl Ed). 2017 Jun;70(6):474-486. doi: 10.1016/j.rec.2016.12.041. Epub 2017 Mar 18. English, Spanish.

PMID:
28330818
2.

[Perception of physicians on factors that influence the choice of a dicoumarin or a new oral anticoagulant in patients with non-valvular atrial fibrillation].

Anguita-Sánchez M, Marco-Vera P, Alonso-Moreno FJ, Arribas-Ynsaurriaga F, Gállego-Culleré J, Honorato-Pérez J, Suárez-Fernández C; Investigadores del estudio ACADEMIC.

Aten Primaria. 2016 Oct;48(8):527-534. doi: 10.1016/j.aprim.2015.11.004. Epub 2016 Mar 10. Spanish.

3.

Cause of Death and Predictors of All-Cause Mortality in Anticoagulated Patients With Nonvalvular Atrial Fibrillation: Data From ROCKET AF.

Pokorney SD, Piccini JP, Stevens SR, Patel MR, Pieper KS, Halperin JL, Breithardt G, Singer DE, Hankey GJ, Hacke W, Becker RC, Berkowitz SD, Nessel CC, Mahaffey KW, Fox KA, Califf RM; ROCKET AF Steering Committee & Investigators; ROCKET AF Steering Committee Investigators.

J Am Heart Assoc. 2016 Mar 8;5(3):e002197. doi: 10.1161/JAHA.115.002197.

4.

Rivaroxaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of ROCKET AF.

Hankey GJ, Patel MR, Stevens SR, Becker RC, Breithardt G, Carolei A, Diener HC, Donnan GA, Halperin JL, Mahaffey KW, Mas JL, Massaro A, Norrving B, Nessel CC, Paolini JF, Roine RO, Singer DE, Wong L, Califf RM, Fox KA, Hacke W; ROCKET AF Steering Committee Investigators.

Lancet Neurol. 2012 Apr;11(4):315-22. doi: 10.1016/S1474-4422(12)70042-X. Epub 2012 Mar 7.

PMID:
22402056
5.

Rivaroxaban versus warfarin in nonvalvular atrial fibrillation.

Patel MR, Mahaffey KW, Garg J, Pan G, Singer DE, Hacke W, Breithardt G, Halperin JL, Hankey GJ, Piccini JP, Becker RC, Nessel CC, Paolini JF, Berkowitz SD, Fox KA, Califf RM; ROCKET AF Investigators.

N Engl J Med. 2011 Sep 8;365(10):883-91. doi: 10.1056/NEJMoa1009638. Epub 2011 Aug 10.

7.

[TAFI plasma levels are not increased in patients with venous thromboembolic disease and factor V Leiden or prothrombin 20210A mutations].

Verdú Belmar J, Marco Vera P, García Hernández C, Lucas Boronat J.

Med Clin (Barc). 2006 Sep 23;127(11):436. Spanish. No abstract available.

PMID:
17020691
8.

[Replacement therapy with protein C for meningococcal sepsis and fulminant purpura in pediatric patients].

Llinares Tello F, Hernández Prats C, Burgos San José A, Bosacoma Ros N, Alcalá Minagorre P, López Rodríguez F, Reig Sáenz R, Marco Vera P, Ordovás Baines JP.

Farm Hosp. 2004 Mar-Apr;28(2):130-6. Spanish.

9.

[Abnormalities in coagulation and fibrinolysis in septic shock with purpura].

Sánchez Miralles A, Reig Sáenz R, Marco Vera P, Muñoz Pérez F, Alvarez Sánchez B, Sebastián Muñoz I.

An Esp Pediatr. 2002 Feb;56(2):99-103. Spanish.

PMID:
11827669
10.

[Thrombogenic and endothelial damage markers in patients with ischemic systolic impairment].

Roldán Schilling V, Marín Ortuño F, Pineda Rocamora J, Climent Payá VE, Martínez Martínez JG, Marco Vera P, de Teresa Parreño L, Sogorb Garri F.

Rev Esp Cardiol. 2001 Oct;54(10):1155-60. Spanish.

11.

Effect of oral anticoagulant therapy on fibrinolysis parameters in chronic non-rheumatic atrial fibrillation.

Roldán-Schilling V, Marín-Ortuño F, Marco-Vera P, Sogorb-Garri F.

Haematologica. 2000 Jul;85(7):778-80. No abstract available.

PMID:
10897143
12.

[Hypercoagulation markers in myocardial infarction].

Marín Ortuño F, Fernández Abellán P, Fernández Carballido C, Roldán Shilling V, Marco Vera P.

An Med Interna. 1999 Nov;16(11):601. Spanish. No abstract available.

PMID:
10638005
13.

[Tissue plasminogen activator as a prognostic factor in myocardial infarct patients].

Fernández Abellán P, Marín Ortuño F, Marco Vera P, Luján Martínez J.

Rev Clin Esp. 1999 Apr;199(4):215-7. Spanish.

PMID:
10364793
14.

[Improvement in fibrinolytic function following anticoagulant treatment in chronic rheumatic atrial fibrillation].

Marín Ortuño F, Roldán Schilling V, Marco Vera P, Martínez Martínez JG, Toral Noguera A, García de Burgos Rico F, Calatayud Sendra R, Sogorb Garri F.

Rev Esp Cardiol. 1999 Jan;52(1):25-30. Spanish.

15.

[Safety of oral anticoagulation in aged patients with heart diseases].

García Garay MC, Marín Ortuño F, Roldán Schilling V, Martínez Martínez JG, Marco Vera P, Sogorb Garri F.

Rev Clin Esp. 1998 May;198(5):294-6. Spanish.

PMID:
9658911
16.

[Levels of antithrombin III and proteins C in the newborn infant].

Abad A, Marco Vera P, Mompel A, García Pérez A.

Sangre (Barc). 1989 Apr;34(2):91-5. Spanish.

PMID:
2756455
17.

[Meningosis in Hand-Schüller-Christian disease].

Marco Vera P, García Peréz AA, Abad Gosálbez A, Mompel Sanjuan A.

Rev Clin Esp. 1989 Mar;184(4):215-6. Spanish. No abstract available.

PMID:
2740557
18.

[Diabetes mellitus and changes in hemostasis: study of the fibrinolytic response of insulin-dependent patients without vascular disease].

García Pérez AA, Marco Vera P, Mompel Sanjuan A, Abad Gosalbez A.

Rev Clin Esp. 1989 Feb;184(3):128-30. Spanish.

PMID:
2717790
19.

[Beta and beta-delta thalassemia heterozygotes in the province of Alicante. Epidemiologic features].

Marco Vera P, Merino Sánchez J.

Sangre (Barc). 1988 Dec;33(6):479-82. Spanish. No abstract available.

PMID:
3247622
20.

[Presentation of 20 cases of lupus anticoagulant. Proposal for a methodology for its study].

Mompel Sanjuán A, Abad Gosalbez A, García Pérez A, Marco Vera P.

Sangre (Barc). 1988 Aug;33(4):306-9. Spanish. No abstract available.

PMID:
3142061

Supplemental Content

Loading ...
Support Center